STOCK TITAN

cbdMD, Inc. - YCBD STOCK NEWS

Welcome to our dedicated page for cbdMD news (Ticker: YCBD), a resource for investors and traders seeking the latest updates and insights on cbdMD stock.

cbdMD, Inc. (NYSE American: YCBD) is a premier provider of high-quality, hemp-derived cannabidiol (CBD) products. Founded in 2015 and headquartered in Charlotte, North Carolina, cbdMD has quickly become one of the most highly trusted and recognized names in the CBD industry. The company offers a broad range of CBD products under its flagship brand cbdMD, as well as its pet-focused brand Paw CBD and its newly launched ATRx Labs line of functional mushroom supplements.

The company's product portfolio includes CBD tinctures, gummies, topicals, capsules, bath bombs, bath salts, sleep aids, and veterinarian-formulated pet CBD products like tinctures, chews, and topicals. It has built a robust distribution network, leveraging its own e-commerce platform, third-party online marketplaces, wholesalers, and a variety of brick-and-mortar retailers across the United States.

In recent developments, cbdMD has introduced innovative products such as the THCV+CBG Energy Softgels, which combine the potency of two dynamic cannabinoids with caffeine and B12 to enhance energy, focus, and clarity. The company's dedication to innovation is also evident in the launch of its CBD+CBG Oil Tincture and the introduction of a new Vice President of Wholesale Sales to expand its market reach.

Financially, cbdMD has been proactive in securing funding to support its growth. Recently, the company entered a securities purchase agreement, raising $1.25 million in gross proceeds to bolster working capital and support the national rollout of its ATRx Labs functional mushroom products. Despite reporting operational losses, cbdMD has implemented cost-cutting measures and strategic initiatives aimed at achieving profitability and enhancing shareholder value.

cbdMD's latest product,

Rhea-AI Summary
cbdMD publishes safety data supporting safe upper dose of proprietary Broad Spectrum CBD blend
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.45%
Tags
none
-
Rhea-AI Summary
cbdMD reminds shareholders to vote ahead of the special meeting on September 22, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.5%
Tags
none
-
Rhea-AI Summary
cbdMD's Paw CBD brand receives 'Dog Hip & Joint Product of the Year' award for their Hip+Joint Soft Chews, enhancing overall wellbeing and supporting mobility in dogs. The chews are certified by NASC and come in three strengths. The award highlights cbdMD's commitment to innovative CBD products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
none
Rhea-AI Summary
cbdMD, Inc. suspends monthly cash dividend on Series A Preferred Stock to conserve cash for sales increase, product development, research, and profitability. Dividends will accumulate until sufficient working capital is restored. Suspension may impact capital raising. Shareholders to vote on automatic conversion of Series A Preferred to common stock on September 22, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
-
Rhea-AI Summary
cbdMD urges FDA for regulatory clarity on CBD products in response to Congressional RFI
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.03%
Tags
none
-
Rhea-AI Summary
cbdMD, Inc. (YCBD) Announces Third Quarter Fiscal 2023 Results: Net Loss Improved to $1.7 Million on Sales of $6.1 Million, Excluding Goodwill and Intangible Impairment of $30.7 Million
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
cbdMD, Inc. will host a conference call on August 10, 2023, at 4:30 p.m. Eastern Time to discuss the company's third quarter of fiscal 2023 financial results and business progress.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
Rhea-AI Summary
cbdMD (NYSE American: YCBD) Announces Launch of Delta 9 THC + CBD Gummies, Introduces Specific Strain-Like Experience Lineup
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.72%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.9%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.31%
Tags
partnership

FAQ

What is the current stock price of cbdMD (YCBD)?

The current stock price of cbdMD (YCBD) is $0.6 as of January 23, 2025.

What is the market cap of cbdMD (YCBD)?

The market cap of cbdMD (YCBD) is approximately 3.2M.

What does cbdMD, Inc. specialize in?

cbdMD, Inc. specializes in producing and distributing high-quality hemp-derived cannabidiol (CBD) products, including tinctures, gummies, topicals, capsules, and pet products.

What are cbdMD's latest product innovations?

cbdMD has recently introduced THCV+CBG Energy Softgels, CBD+CBG Oil Tincture, and Max Chill Dragon Fruit D9 Gummies, as well as launching the ATRx Labs line of functional mushroom supplements.

How does cbdMD distribute its products?

cbdMD distributes its products through its e-commerce website, third-party online marketplaces, wholesalers, and various brick-and-mortar retailers in the United States.

What recent financial steps has cbdMD taken?

cbdMD recently entered a securities purchase agreement to raise $1.25 million in gross proceeds to support working capital and the national rollout of its ATRx Labs products.

What is the significance of cbdMD's ATRx Labs line?

The ATRx Labs line focuses on functional mushroom supplements designed to support various health needs. It marks cbdMD's expansion into non-CBD health products.

Is cbdMD financially stable?

While cbdMD has reported operational losses, it has implemented significant cost-cutting measures and strategic initiatives aimed at achieving profitability and enhancing shareholder value.

What challenges is cbdMD currently facing?

cbdMD received a notice from the NYSE American regarding non-compliance with certain listing standards. The company is working on a compliance plan to address this issue.

Where is cbdMD headquartered?

cbdMD is headquartered in Charlotte, North Carolina.

Who recently joined the cbdMD team?

Joe Baghadjian recently joined cbdMD as Vice President of Wholesale Sales, bringing extensive experience in CBD sales and a scientific background.

What are cbdMD's future plans?

cbdMD plans to focus on achieving positive net income, expanding its product offerings, and enhancing its market presence through strategic initiatives and cost-cutting measures.
cbdMD, Inc.

NYSE:YCBD

YCBD Rankings

YCBD Stock Data

3.23M
4.91M
16.11%
3.33%
4.32%
Drug Manufacturers - Specialty & Generic
Perfumes, Cosmetics & Other Toilet Preparations
Link
United States of America
CHARLOTTE